Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study

The Lancet Neurology

Volumn 15, Issue 7, 2016, Pages 708-718

  Vilas, Dolores ^a,c   Iranzo, Alex ^a,c   Tolosa, Eduardo ^a,c   Aldecoa, Iban ^a   Berenguer, Joan ^a   Vilaseca, Isabel ^a,d   Martí, Carles ^a   Serradell, Mónica ^a   Lomeña, Francisco ^a   Alós, Llucia ^a   Gaig, Carles ^a   Santamaria, Joan ^a   Gelpi, Ellen ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ARTICLE; AUTOPSY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HEMATOMA; HOEHN AND YAHR SCALE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEEDLE BIOPSY; NEURITE; PARASOMNIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SPAIN; SUBMANDIBULAR GLAND; SUBSTANTIA NIGRA; UNIFIED PARKINSON DISEASE RATING SCALE; XEROSTOMIA; LARGE CORE NEEDLE BIOPSY; METABOLISM; NERVE FIBER;

AGED; ALPHA-SYNUCLEIN; BIOPSY, LARGE-CORE NEEDLE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE FIBERS; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER; SPAIN; SUBMANDIBULAR GLAND;

EID: 84962118986     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(16)00080-6     Document Type: Article

References (42)

1. Tolosa, E, Wenning, G, Poewe, W, The diagnosis of Parkinson's disease. Lancet Neurol 5 (2006), 75–86.
2. Dickson, DW, Braak, H, Duda, JE, et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 8 (2009), 1150–1157.
3. Jellinger, KA, Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm 122 (2015), 1429–1440.
4. Braak, H, Rüb, U, Gai, WP, Del Tredici, K, Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110 (2003), 517–536.
5. Tolosa, E, Pont-Sunyer, C, Progress in defining the premotor phase of Parkinson's disease. J Neurol Sci 310 (2011), 4–8.
6. Orimo, S, Uchihara, T, Nakamura, A, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 131 (2008), 642–650.
7. Probst, A, Bloch, A, Tolnay, M, New insights into the pathology of Parkinson's disease: does the peripheral autonomic system become central?. Eur J Neurol 15:suppl 1 (2008), 1–4.
8. Miki, Y, Mori, F, Wakabayashi, K, Kuroda, N, Orimo, S, Incidental Lewy body disease restricted to the heart and stellate ganglia. Mov Disord 24 (2009), 2299–2301.
9. Cersosimo, MG, Benarroch, EE, Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J Neurol Sci 313 (2012), 57–63.
10. Adler, CH, Dugger, BN, Hinni, ML, et al. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology 82 (2014), 858–864.
11. Adler, CH, Dugger, BN, Hentz, JG, et al. Peripheral synucleinopathy in early Parkinson's disease: submandibular gland needle biopsy findings. Mov Disord, 2016, 10.1002/mds.26476 published online Jan 22.
12. Iranzo, A, Santamaria, J, Tolosa, E, Idiopathic rapid-eye-movement sleep disorder. Lancet Neurol 15 (2016), 405–419.
13. Schenck, CH, Boeve, BF, Mahowald, MW, Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14 (2013), 744–748.
14. Iranzo, A, Tolosa, E, Gelpi, E, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behavior disorder: an observational cohort study. Lancet Neurol 12 (2013), 443–453.
15. American Academy of Sleep Medicine. International classification of sleep disorders, 3rd edn., 2014, American Academy of Sleep Medicine, Darien.
16. Goetz, CG, Tilley, BC, Shaftman, SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23 (2008), 2129–2170.
17. Cerosimo, MG, Raina, GB, Calandra, CR, et al. Dry mouth: an overlooked autonomic symptom of Parkinson's disease. J Parkinsons Dis 1 (2011), 169–173.
18. Doty, RL, The smell identification test TM administration manual, 3rd edn., 1995, Sensonics, Philadephia.
19. Iranzo, A, Serradell, M, Vilaseca, I, et al. Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord 19 (2013), 600–604.
20. Longstreth, GF, Thompson, WG, Chey, WD, Houghton, LA, Mearin, F, Spiller, RC, Functional bowel disorders. Gastroenterology 130 (2006), 1480–1491.
21. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 1994, American Psychiatric Association, Washington.
22. Vilas, D, Iranzo, A, Pont-Sunyer, C, et al. Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression. J Neurol 262 (2015), 1665–1672.
23. Iranzo, A, Lomeña, F, Stockner, H, et al., for the Sleep Innsbruck Barcelona (SINBAR) group. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 9 (2010), 1070–1077.
24. Hughes, AJ, Daniel, SE, Kilford, L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992), 181–184.
25. Hoehn, MM, Yahr, MD, Parkinsonism: onset, progression and mortality. Neurology 17 (1967), 427–442.
26. Aldecoa, I, Navarro-Otano, J, Stefanova, N, et al. Alpha-synuclein immunoreactivity patterns in the enteric nervous system. Neurosci Lett 602 (2015), 145–149.
27. Schindelin, J, Arganda-Carreras, I, Frise, E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 9 (2012), 676–682.
28. Montine, TJ, Phelps, CH, Beach, TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 123 (2012), 1–11.
29. Crary, JF, Trojanowski, JQ, Schneider, JA, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128 (2014), 755–766.
30. Kovacs, GG, Ferrer, I, Gringberg, LT, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131 (2016), 87–102.
31. Miki, Y, Tomiyama, M, Ueno, T, et al. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease. Neurosci Lett 469 (2010), 357–359.
32. Lebouvier, T, Neunlist, M, Bruley des Varannes, S, et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One, 5, 2010, e12728.
33. Folgoas, E, Lebouvier, T, Leclair-Visonneau, L, et al. Diagnostic value of minor salivary glands for the detection of Lewy pathology. Neurosci Lett 551 (2013), 62–64.
34. Beach, TG, Adler, CH, Sue, LI, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119 (2010), 689–702.
35. Beach, TG, Adler, CH, Dugger, BN, et al. Submandibular gland biopsy for the diagnosis of Parkinson disease. J Neuropathol Exp Neurol 72 (2013), 130–136.
36. Del Tredici, K, Hawkes, CH, Ghebremedhin, E, Braak, H, Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol 119 (2010), 703–713.
37. Silver, AR, Som, PM, Salivary glands. Radiol Clin North Am 36 (1998), 941–966.
38. Boeve, BF, Silber, MH, Ferman, TJ, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med 14 (2013), 754–762.
39. Boeve, BF, Dickson, DW, Olson, EJ, et al. Insights into REM sleep behaviour disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med 8 (2007), 60–64.
40. Iranzo, A, Gelpi, E, Tolosa, E, et al. Neuropathology of prodromal Lewy body disease. Mov Disord 29 (2014), 410–415.
41. Gelpi, E, Navarro-Otano, J, Tolosa, E, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord 29 (2014), 1010–1018.
42. Sprenger, FS, Stefanova, N, Gelpi, E, et al. Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder. Neurology 85 (2015), 1761–1768.